Cargando…

Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review

Detalles Bibliográficos
Autores principales: Xing, Lijie, He, Qiang, Xie, Linna, Wang, Hui, Li, Zengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052906/
https://www.ncbi.nlm.nih.gov/pubmed/34937321
http://dx.doi.org/10.3324/haematol.2021.280259
_version_ 1784696882416582656
author Xing, Lijie
He, Qiang
Xie, Linna
Wang, Hui
Li, Zengjun
author_facet Xing, Lijie
He, Qiang
Xie, Linna
Wang, Hui
Li, Zengjun
author_sort Xing, Lijie
collection PubMed
description
format Online
Article
Text
id pubmed-9052906
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-90529062022-05-13 Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review Xing, Lijie He, Qiang Xie, Linna Wang, Hui Li, Zengjun Haematologica Case Reports Fondazione Ferrata Storti 2021-12-23 /pmc/articles/PMC9052906/ /pubmed/34937321 http://dx.doi.org/10.3324/haematol.2021.280259 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Case Reports
Xing, Lijie
He, Qiang
Xie, Linna
Wang, Hui
Li, Zengjun
Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review
title Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review
title_full Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review
title_fullStr Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review
title_full_unstemmed Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review
title_short Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review
title_sort zanubrutinib, rituximab and lenalidomide induces deep and durable remission in tp53-mutated b-cell prolymphocytic leukemia: a case report and literature review
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052906/
https://www.ncbi.nlm.nih.gov/pubmed/34937321
http://dx.doi.org/10.3324/haematol.2021.280259
work_keys_str_mv AT xinglijie zanubrutinibrituximabandlenalidomideinducesdeepanddurableremissionintp53mutatedbcellprolymphocyticleukemiaacasereportandliteraturereview
AT heqiang zanubrutinibrituximabandlenalidomideinducesdeepanddurableremissionintp53mutatedbcellprolymphocyticleukemiaacasereportandliteraturereview
AT xielinna zanubrutinibrituximabandlenalidomideinducesdeepanddurableremissionintp53mutatedbcellprolymphocyticleukemiaacasereportandliteraturereview
AT wanghui zanubrutinibrituximabandlenalidomideinducesdeepanddurableremissionintp53mutatedbcellprolymphocyticleukemiaacasereportandliteraturereview
AT lizengjun zanubrutinibrituximabandlenalidomideinducesdeepanddurableremissionintp53mutatedbcellprolymphocyticleukemiaacasereportandliteraturereview